Strive, Inc. (NASDAQ: ASST) operates in a competitive market, focusing on innovative solutions and services. As it prepares to release its quarterly earnings on March 16, 2026, analysts predict an earnings per share (EPS) of -$0.20 and revenue of approximately $1.67 million. This release is crucial for investors and analysts who are closely monitoring the company's financial health.
Recently, ASST's stock experienced a notable increase, opening at $9.36 and last trading at $9.96, with a trading volume exceeding 1.2 million shares. This surge in stock price comes ahead of the earnings release, reflecting investor interest and market speculation. Despite the negative EPS forecast, the stock's movement suggests optimism among investors.
Several research analysts have shared their perspectives on ASST. Wall Street Zen and Zacks Research both upgraded the stock to a "hold" rating, indicating a neutral stance. B. Riley Financial initiated coverage with a "buy" rating and a target price of $12.00, while Maxim Group set an ambitious target price of $30.00, also recommending a "buy." However, Weiss Ratings maintained a "sell (e-)" rating, highlighting differing opinions on the company's prospects.
ASST's financial metrics reveal a complex picture. The negative price-to-earnings (P/E) ratio of -0.08 indicates current losses, while the price-to-sales ratio of 15.81 suggests investors are paying a premium for each dollar of sales. The enterprise value to sales ratio is notably negative at -32.70, pointing to valuation challenges. However, the enterprise value to operating cash flow ratio of 1.52 suggests efficient cash flow conversion.
The company's financial stability is underscored by a debt-to-equity ratio of 0.009, indicating minimal debt. Additionally, a current ratio of 11.97 reflects strong liquidity, suggesting ASST can comfortably meet its short-term obligations. Despite a negative earnings yield of -11.99%, these metrics provide a mixed view of the company's financial health, with both challenges and strengths evident.
